Khalid Usman (2021) “EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION”, Journal of Population Therapeutics and Clinical Pharmacology, 28(2), pp. 418–422. doi:10.53555/jptcp.v28i2.6807.